Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Adverum, Avrobio, Anavex, Bellus, Celixir, CSL, Deciphera, Gensight, Gilead, Idorsia, Immunomedics, Inventiva, Merck, Myovant, Obseva, Oryzon, Sunovion, Regeneron, Sanofi.